News

Florida company buys share of Avicanna

Published on July 3, 2026 by Pat Bulmer

Photo: Contributed

Florida-based Splash Beverage Group has made a $300,000 investment in Canadian cannabinoid producer Avicanna Inc.

“The investment represents a strategic capital allocation aligned with Splash’s previously announced transformation into a cannabinoid-based health, wellness, and healthcare-focused platform company,” the Fort Lauderdale company said in a news release. “Splash believes Avicanna has assembled one of the most sophisticated cannabinoid healthcare platforms operating today and is uniquely positioned for the continued evolution of the medical cannabinoid market in the United States.”

“As we evaluated opportunities across the sector, Avicanna stood out because of its combination of intellectual property, product portfolio, clinical development, healthcare-system integration, managing health insurance filings and integration, pharmaceutical expertise, and operational execution,” said Brady Cobb, Splash’s interim CEO.

Splash cited several attributes that made Avicanna stand out, including:

— It is one of North America’s leading cannabinoid-based biopharmaceutical companies with proprietary formulations and clinical-stage pharmaceutical assets;

— It has a commercial-stage pharmaceutical portfolio that includes Trunerox, an approved cannabidiol treatment for severe epilepsy

— MyMedi.ca is one of Canada’s leading medical cannabis care platforms

— Avicanna has an experienced management team and a debt-free balance sheet.

“In many respects, Avicanna has built and operated within a federally regulated medical cannabinoid framework that already incorporates many of the characteristics increasingly being evaluated across the United States healthcare system,” said Cobb.

The $300,000 bought two million shares and one million warrants (future shares). Avicanna raised $600,000 in a share offering from all buyers.